Skip to content

Evaluating the Combined Effect of Tretinoin Gel 0.1% and Minoxidil 5% ( ST- Rich Duo) in Treating Androgenic Alopecia

Assessment of Efficacy and Safety of ST-Richduo (Tretinoin gel 0.1% with topical minoxidil 5%) in the Treatment of Androgenic Alopecia - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/070432
Enrollment
20
Registered
2024-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L649- Androgenic alopecia, unspecified

Interventions

Intervention1: ST- Rich Duo (Tretinoin 0.1% with topical minoxidil 5%): Apply to the scalp twice daily at morning & night for 12 weeks. In Night: Apply 1 ML of ST Rich Booster (Tretinoin 0.1% gel) a

Sponsors

Regaliz Medicare Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Male & Female, between 18-45 years of age diagnosed with AGA and MPHL. 2.Norwood-Hamilton grades II to V. 3.Ludwig grades I and II. 3.Clinically diagnosed as Minoxidil non responder / partial responder based on global photography assessment. 5.Minoxidil non responder / partial responder based on Minoxidil Response Test. 6.Able to give informed consent.

Exclusion criteria

Exclusion criteria: 1.Subjects on isotretinoin, radiation to the scalp, or chemotherapy within past 1 year 2.Use of any other AGA treatment during past 6 months 3.Subjects on botanicals/nutraceuticals for hair regrowth for the past 3 months 4.Men with uncontrolled hypertension or history of hypotension 5.Any chronic active scalp condition other than AGA 6.History of scalp reduction or use of hair weaves 7.Pregnant or lactating women

Design outcomes

Primary

MeasureTime frame
Percentage change in the proportion of anagen hair using frontal, temporal, and vertex trichoscopy in the treatmentTimepoint: Baseline to 12 weeks of treatment

Secondary

MeasureTime frame
Percentage change in the proportion of anagen hair using frontal, temporal, and vertex trichoscopy in the treatment Assessment of global scalp photograph by investigator and subjects using 5 point scale (scale of 0 ?4 (0: No improvement; 1: 1 ?25% improvement; 2: 26 ?50% improvement; 3: 51 ?75% improvement; 4: 76 ?100% improvement).Timepoint: Baseline to 12 weeks of treatment

Countries

India

Contacts

Public ContactDr B S Chandrashekar

CUTIS Academy of Cutaneous Sciences

cutisclinic@gmail.com9740091155

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026